1.    Research Framework

1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.    Research Methodology

2.1. Qualitative Research

2.1.1.   Primary & Secondary Research

2.2. Quantitative Research

2.3. Market Breakdown & Data Triangulation

2.3.1.   Secondary Research

2.3.2.   Primary Research

2.4. Breakdown of Primary Research Respondents, By Region

2.5. Assumption & Limitation

3.    Executive Summary

4.    Global Autoinjectors Market Insights

4.1. Industry Value Chain Analysis

4.2. DROC Analysis

4.2.1.   Growth Drivers

4.2.2.   Restraints

4.2.3.   Opportunities

4.2.4.   Challenges

4.3. Recent Development

4.4. Government Regulations

4.5. Porter’s Five Forces Analysis

4.5.1.   Bargaining Power of Suppliers

4.5.2.   Bargaining Power of Buyers

4.5.3.   Threat of New Entrants

4.5.4.   Threat of Substitutes

4.5.5.   Intensity of Rivalry

5.    Global Autoinjectors Market Overview

5.1. Market Size & Forecast by Value, 2017-2027

5.1.1.   By Value (USD Million)

5.2. Market Share & Forecast

5.2.1.   By Type

5.2.1.1.       Disposable

5.2.1.2.       Reusable

5.2.2.   By Therapy

5.2.2.1.       Rheumatoid Arthritis

5.2.2.2.       Diabetes

5.2.2.3.       Multiple Sclerosis

5.2.2.4.       Anaphylaxis

5.2.2.5.       Other Therapies

5.2.3.   By Route of Administration

5.2.3.1.       Subcutaneous

5.2.3.2.       Intramuscular

5.2.4.   By End-Users

5.2.4.1.       Homecare

5.2.4.2.       Hospitals & Clinics

5.2.4.3.       Ambulatory Care Settings

5.2.5.   By Region

5.2.5.1.     North America

5.2.5.2.     Europe

5.2.5.3.     Asia Pacific

5.2.5.4.     Latin America

5.2.5.5.     Middle East and Africa

6.    North America Autoinjectors Market  

6.1. Market Size & Forecast by Value, 2017-2027

6.1.1.   By Value (USD Million)

6.2. Market Share & Forecast

6.2.1.   By Type

6.2.2.   By Therapy

6.2.3.   By Route of Administration

6.2.4.   By End-Users

6.2.5.   By Country

6.2.5.1.     U.S.

6.2.5.2.     Canada

7.    Europe Autoinjectors Market

7.1. Market Size & Forecast by Value, 2017-2027

7.1.1.   By Value (USD Million)

7.2. Market Share & Forecast

7.2.1.   By Type

7.2.2.   By Therapy

7.2.3.   By Route of Administration

7.2.4.   By End-Users

7.2.5.   By Country

7.2.5.1.     Germany

7.2.5.2.     United Kingdom

7.2.5.3.     Italy

7.2.5.4.     France

7.2.5.5.     Spain

7.2.5.6.     Rest of Europe

8.    Asia Pacific Autoinjectors Market

8.1. Market Size & Forecast by Value, 2017-2027

8.1.1.   By Value (USD Million)

8.2. Market Share & Forecast

8.2.1.   By Type

8.2.2.   By Therapy

8.2.3.   By Route of Administration

8.2.4.   By End-Users

8.2.5.   By Country

8.2.5.1.     China

8.2.5.2.     India

8.2.5.3.     Japan

8.2.5.4.     Australia

8.2.5.5.     South Korea

8.2.5.6.     Rest of Asia Pacific

9.    Latin America Autoinjectors Market

9.1.  Market Size & Forecast by Value, 2017-2027

9.1.1.       By Value (USD Million)

9.2. Market Share & Forecast

9.2.1.       By Type

9.2.2.       By Therapy

9.2.3.       By Route of Administration

9.2.4.       By End-Users

9.2.5.       By Country

9.2.5.1.     Brazil

9.2.5.2.     Mexico

9.2.5.3.     Argentina

9.2.5.4.     Rest of Latin America

10.Middle East & Africa Autoinjectors Market

10.1. Market Size & Forecast by Value, 2017-2027

10.1.1.  By Value (USD Million)

10.2. Market Share & Forecast

10.2.1.    By Type

10.2.2.    By Therapy

10.2.3.    By Route of Administration

10.2.4.    By End-Users

10.2.5.    By Country

10.2.5.1.  Saudi Arabia

10.2.5.2.  Turkey

10.2.5.3.  UAE

10.2.5.4.  South Africa

10.2.5.5.  Rest of Middle East & Africa

11.Competitive Landscape

11.1.          List of Key Players and Their Offerings

11.2.          Market Share Analysis, 2020

11.3.          Competitive Benchmarking, By Operating Parameters

12.Impact of Covid-19 on Autoinjectors Market Industry

13.Company Profile (Company Overview, Financial Matrix, Competitive landscape, Key Personnel, Key Competitors, Contact Address, and Strategic Outlook)

13.1.        AbbVie Inc.

13.2.        Mylan

13.3.        Eli Lilly and Company

13.4.        Ypsomed

13.5.        Amgen

13.6.        Becton, Dickinson and Company

13.7.        GlaxoSmithKline plc

13.8.        Johnson & Johnson

13.9.        Teva Pharmaceutical

13.10.     Antares Pharma

13.11.     Merck KGaA

13.12.     Other Prominent Players

14.Key Strategic Recommendations

 

List of Figures

 

Fig: Global Autoinjectors Segmentation

Fig: Global Autoinjectors Market Value Chain Analysis

Fig: Company Market Share Analysis, 2020

Fig: Global Autoinjectors Market Size, By Value (USD Million), 2017-2027

Fig: Global Autoinjectors Market Share, By Type, By Value, 2017-2027

Fig: Global Autoinjectors Market Share, By Therapy, By Value, 2017-2027

Fig: Global Autoinjectors Market Share, By Route of Administration, By Value, 2017-2027

Fig: Global Autoinjectors Market Share, By End-Users, By Value, 2017-2027

Fig: Global Autoinjectors Market Share, By Region, By Value, 2017-2027

Fig: North America Autoinjectors Market Size, By Value (USD Million), 2017-2027

Fig: North America Autoinjectors Market Share, By Type, By Value, 2017-2027

Fig: North America Autoinjectors Market Share, By Therapy, By Value, 2017-2027

Fig: North America Gowns Market Share, By Route of Administration, By Value, 2017-2027

Fig: North America Autoinjectors Market Share, By End-Users, By Value, 2017-2027

Fig: North America Autoinjectors Market Share, By Country, By Value, 2017-2027

Fig: Europe Autoinjectors Market Size, By Value (USD Million), 2017-2027

Fig: Europe Autoinjectors Market Share, By Type, By Value, 2017-2027

Fig: Europe Autoinjectors Market Share, By Therapy, By Value, 2017-2027

Fig: Europe Autoinjectors Market Share, By Route of Administration, By Value, 2017-2027

Fig: Europe Autoinjectors Market Share, By End-Users, By Value, 2017-2027

Fig: Europe Autoinjectors Market Share, By Country, By Value, 2017-2027

Fig: Asia-Pacific Autoinjectors Market Size, By Value (USD Million), 2017-2027

Fig: Asia-Pacific Autoinjectors Market Share, By Type, By Value, 2017-2027

Fig: Asia-Pacific Autoinjectors Market Share, By Therapy, By Value, 2017-2027

Fig: Asia-Pacific Autoinjectors Market Share, By Route of Administration, By Value, 2017-2027

Fig: Asia-Pacific Autoinjectors Market Share, By End-Users, By Value, 2017-2027

Fig: Asia-Pacific Autoinjectors Market Share, By Country, By Value, 2017-2027

Fig: Latin America Autoinjectors Market Size, By Value (USD Million), 2017-2027

Fig: Latin America Autoinjectors Market Share, By Type, By Value, 2017-2027

Fig: Latin America Autoinjectors Market Share, By Therapy, By Value, 2017-2027

Fig: Latin America Autoinjectors Market Share, By Route of Administration, By Value, 2017-2027

Fig: Latin America Autoinjectors Market Share, By End-Users, By Value, 2017-2027

Fig: Latin America Autoinjectors Market Share, By Country, By Value, 2017-2027

Fig: Middle East & Africa Autoinjectors Market Size, By Value (USD Million), 2017-2027

Fig: Middle East & Africa Autoinjectors Market Share, By Type, By Value, 2017-2027

Fig: Middle East & Africa Autoinjectors Market Share, By Therapy, By Value, 2017-2027

Fig: Middle East & Africa Autoinjectors Market Share, By Route of Administration, By Value, 2017-2027

Fig: Middle East & Africa Autoinjectors Market Share, By End-Users, By Value, 2017-2027

Fig: Middle East & Africa Autoinjectors Market Share, By Country, By Value, 2017-2027

 

List of Table

Table: Global Autoinjectors Market Size, By Type, By Value, 2017-2027

Table: Global Autoinjectors Market Size, By Therapy, By Value, 2017-2027

Table: Global Autoinjectors Market Size, By Route of Administration, By Value, 2017-2027

Table: Global Autoinjectors Market Size, By End-Users, By Value, 2017-2027

Table: Global Autoinjectors Market Size, By Region, By Value, 2017-2027

Table: North America Autoinjectors Market Size, By Type, By Value, 2017-2027

Table: North America Autoinjectors Market Size, By Therapy, By Value, 2017-2027

Table: North America Autoinjectors Market Size, By Route of Administration, By Value, 2017-2027

Table: North America Autoinjectors Market Size, By End-Users, By Value, 2017-2027

Table: North America Autoinjectors Market Size, By Country, By Value, 2017-2027

Table: Europe Autoinjectors Market Size, By Type, By Value, 2017-2027

Table: Europe Autoinjectors Market Size, By Therapy, By Value, 2017-2027

Table: Europe Autoinjectors Market Size, By Route of Administration, By Value, 2017-2027

Table: Europe Autoinjectors Market Size, By End-Users, By Value, 2017-2027

Table: Europe Autoinjectors Market Size, By Country, By Value, 2017-2027

Table: Asia-Pacific Autoinjectors Market Size, By Type, By Value, 2017-2027

Table: Asia-Pacific Autoinjectors Market Size, By Therapy, By Value, 2017-2027

Table: Asia-Pacific Autoinjectors Market Size, By Route of Administration, By Value, 2017-2027

Table: Asia-Pacific Autoinjectors Market Size, By End-Users, By Value, 2017-2027

Table: Asia-Pacific Autoinjectors Market Size, By Country, By Value, 2017-2027

Table: Latin America Autoinjectors Market Size, By Type, By Value, 2017-2027

Table: Latin America Autoinjectors Market Size, By Therapy, By Value, 2017-2027

Table: Latin America Autoinjectors Market Size, By Route of Administration, By Value, 2017-2027

Table: Latin America Autoinjectors Market Size, By End-Users, By Value, 2017-2027

Table: Latin America Autoinjectors Market Size, By Country, By Value, 2017-2027

Table: Middle East & Africa Autoinjectors Market Size, By Type, By Value, 2017-2027

Table: Middle East & Africa Autoinjectors Market Size, By Therapy, By Value, 2017-2027

Table: Middle East & Africa Autoinjectors Market Size, By Route of Administration, By Value, 2017-2027

Table: Middle East & Africa Autoinjectors Market Size, By End-Users, By Value, 2017-2027

Table: Middle East & Africa Autoinjectors Market Size, By Country, By Value, 2017-2027

Table: AbbVie Inc. Inc Financial Analysis

Table: Mylan Financial Analysis

Table: Eli Lilly and Company Financial Analysis

Table: Ypsomed Financial Analysis

Table: Becton, Dickinson and Company Financial Analysis

Table: Miltenyi Biotec Financial Analysis

Table: Charles River Laboratories Financial Analysis

Table: GlaxoSmithKline plc Financial Analysis

Table: Johnson & Johnson Financial Analysis

Table: Teva Pharmaceutical Financial Analysis

Table: Antares Pharma Financial Analysis

Table: Merck KGaA Financial Analysis